Roderick Joseph Coombs

Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

Kowa Pharmaceuticals America, Inc. manufactures pharmaceutical products. It specializes in the areas of cardiology, pain and migraine. The firm also focuses on the acquisition, development, licensing, and marketing of pharmaceutical products. The company was founded in July 2008 by Carl Whatley and is headquartered in Montgomery, AL.

Kowa (Shanghai) Pharma Consulting Co., Ltd. engages in prescription drugs, health products, and medical information consulting. The company was founded on August 24, 2007 and is headquartered in Shanghai, China.

Kowa Holdings Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies. It focuses on firms that specialize in research, development, production, trade, as well as sale and wholesale of pharmaceutical and chemical products, fashion, interior design, medical products, and lenses. The company was founded on February 8, 2016 and is headquartered in Zurich, Switzerland.

Kowa Pharmaceutical Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies that specialize in research, development, production, trade, distribution, as well as wholesale of pharmaceutical, medical, health, and chemical products. The company was founded on December 6, 2016 and is headquartered in Zurich, Switzerland.

Kowa Health Care (Shanghai) Import & Export Co., Ltd. engages in the sale of medical equipment. It also offers cosmetics, electronic products, sanitary products, sports goods, and textile products. Its business activities include marketing planning, and management consulting services. The company was founded on August 13, 2012 and is headquartered in Shanghai, China.

Kowa Research Europe Ltd. engages in research and experimental development on social sciences and humanities. The firm develops NK-104, Pitavastatin; K-877, Pemafibrate; K-333, Peretinoin; and K-115, Ripasudil compounds. The company was founded on January 12, 1999 and is headquartered in Wokingham, the United Kingdom.